Literature DB >> 19742390

From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up.

Joanna Siuda1, Agnieszka Gorzkowska, Maja Patalong-Ogiewa, Ewa Krzystanek, Ewa Czech, Barbara Wiechuła, Wojciech Garczorz, Alojzy Danch, Barbara Jasińska-Myga, Grzegorz Opala.   

Abstract

BACKGROUND AND
PURPOSE: People with mild cognitive impairment (MCI) have higher risk of developing dementia than the general population. Currently known risk factors for dementia include older age, low education level, gait disorders, hippocampal atrophy, and apolipoprotein E allele. Vascular risk factors may modify the neurodegenerative process. The aim of this study was therefore to assess the influence of vascular (genetic and environmental) risk factors on progression to dementia in an MCI group during a one-year period.
MATERIAL AND METHODS: Fifty-five MCI patients (30 men and 25 women) and 44 controls (25 men and 19 women) matched for age, gender and education were studied. Mild cognitive impairment was diagnosed according to Petersen criteria (Mayo Clinic Group). Neuropsychological evaluation was made. Assessed vascular risk factors included hypertension, cardiovascular disease, diabetes, cigarette smoking, hyperlipidaemia, hyperhomocysteinaemia with vitamin B12 and folate deficiency. Genetic risk factors (APOE polymorphism, C677T and A1298C MTHFR polymorphisms) were also assessed.
RESULTS: Vascular risk factors were found significantly more often in the MCI group (p = 0.041), including APOE4 allele (p = 0.018), hyperhomocysteinaemia (p = 0.012) and folate deficiency (p = 0.023). Discriminant function analysis showed that only age and hypertension are potential factors which may have an influence on progression to dementia in the MCI group within one year of prospective observation.
CONCLUSION: Vascular risk factors are associated with cognitive impairment but do not have a significant influence on progression to dementia in the MCI group.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19742390

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  8 in total

1.  Oxidative stress impairs learning and memory in apoE knockout mice.

Authors:  Marianne Evola; Allyson Hall; Trevor Wall; Alice Young; Paula Grammas
Journal:  Pharmacol Biochem Behav       Date:  2010-05-08       Impact factor: 3.533

2.  Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research.

Authors:  Blossom C M Stephan; Carol Brayne; George M Savva; Fiona E Matthews
Journal:  Age Ageing       Date:  2011-07       Impact factor: 10.668

Review 3.  Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease.

Authors:  Maritha J Kotze; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2012-04-19       Impact factor: 3.584

4.  Domain specific changes in cognition at high altitude and its correlation with hyperhomocysteinemia.

Authors:  Vijay K Sharma; Saroj K Das; Priyanka Dhar; Kalpana B Hota; Bidhu B Mahapatra; Vivek Vashishtha; Ashish Kumar; Sunil K Hota; Tsering Norboo; Ravi B Srivastava
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

5.  Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.

Authors:  Nick van Wijk; Rosalinde E R Slot; Flora H Duits; Marieke Strik; Egbert Biesheuvel; John W C Sijben; Marinus A Blankenstein; Jörgen Bierau; Wiesje M van der Flier; Philip Scheltens; Charlotte E Teunissen
Journal:  Alzheimers Dement (Amst)       Date:  2017-05-16

6.  Association of Methylenetetrahydrofolate Reductase C677T Gene Polymorphisms with Mild Cognitive Impairment Susceptibility: A Systematic Review and Meta-Analysis.

Authors:  Jiahui Sun; Xuefan Jiang; Ming Zhao; Lina Ma; Hui Pei; Nanyang Liu; Hao Li
Journal:  Behav Neurol       Date:  2021-09-18       Impact factor: 3.342

7.  Plasma Cytokines Profile in Subjects with Alzheimer's Disease: Interleukin 1 Alpha as a Candidate for Target Therapy.

Authors:  Meisam Mahdavi; Saeed Karima; Shima Rajaei; Vajihe Aghamolaii; Hossein Ghahremani; Reza Ataei; Hessam Sepasi Tehrani; Somayeh Mahmoodi Baram; Abbas Tafakhori; Behnam Safarpour Lima; Somayeh Shateri; Hamid Fatemi; Farzad Mokhtari; Abdolrahim Nikzameer; Amir Yarhosseini; Ali Gorji
Journal:  Galen Med J       Date:  2021-01-25

8.  A novel screening tool (Karanth's test) for vitamin B12 deficiency: a pilot study.

Authors:  Veena K L Karanth; Laxminarayan Karanth; Tulasi K Karanth; Sowmyashree K Karanth; Ragini Bekur
Journal:  BMC Res Notes       Date:  2015-12-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.